We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update; exclusivity agreement with Microsaic

20 Dec 2023 12:30

RNS Number : 4962X
Deepverge PLC
20 December 2023
 

20 December 2023

 

DeepVerge plc

 

("DeepVerge" or "the Company")

 

Update; exclusivity agreement with Microsaic

 

Further to the previous notification on 13 December 2023, the Company has today entered into an agreement with Microsaic Systems plc ("Microsaic") granting Microsaic a period of exclusivity ("Exclusivity Period") in respect of the potential sale of certain assets currently held within subsidiaries relating to its Modern Water business ("the 'Business").

The assets broadly comprise equipment for the laboratory-based manufacturing of bio-reagents used in related water testing equipment currently based at the Company's York laboratory and include all IP and rights to the related water testing equipment including LX, FX and Continuous Toxic Measuring ("CTM") machines and water membrane technology.

The Business specifically excludes the voltammetry technology and equipment manufactured by B3 Electronic Design Pty Ltd in Perth, Australia.

The granting of the Exclusivity Period follows the receipt of an indicative outline proposal from Microsaic to purchase the Business for £100,000 in cash payable on completion ('the Proposal').

 

In addition upon completion Microsaic Systems is willing to discharge all intra company debt (sum to be verified) between DeepVerge and Microsaic as part of the consideration for the acquisition.

 

The Exclusivity Period runs until the earlier of (a) 16 January 2024, (b) the signature of a legally binding sale & purchase agreement between the DeepVerge and Microsaic for the Business ("the Transaction") and (c) withdrawal of the Proposal by Microsaic.

No consideration has been received by DeepVerge for the granting of the Exclusivity Period.

During the Exclusivity Period DeepVerge shall not solicit, advertise, market or enter any other negotiations, arrangements or options with any third parties relating to the sale of the Business and shall not complete the Transaction other than with Microsaic.

The Exclusivity Period may, at its sole discretion, be extended by Deepverge for a further period for the Transaction to be finalised.

The Exclusivity Period is designed to provide Microsaic with time to conclude its due diligence, obtain binding commitments for a fundraising, including working capital for the enlarged Microsaic business, and consideration for the Transaction, and to negotiate and sign a detailed sale and purchase agreement. There is no guarantee that the Transaction will occur, or that the outline terms indicated in the Proposal will be those on which a binding agreement is signed. As previously notified on 13 December 2023, any proceeds from a disposal transaction is likely to realise insufficient value to avoid the closure or administration of the relevant Group subsidiaries.

DeepVerge director Dr Nigel Burton is also a director of Microsaic. Given his conflict of interest, Dr Burton is not involved in the DeepVerge board's consideration of the Transaction. Ross Andrews is the only independent director ("Independent Director").

As previously notified, the cancellation of the admission of the Company's shares to trading on AIM ("Cancellation") is expected therefore to take place with effect from 7.00 a.m. on 27 December 2023.

If the Transaction occurs before the date of Cancellation it would constitute a related party transaction under the AIM Rules for Companies (the "AIM Rules") and would require treatment in accordance with AIM Rule 13 (related party transactions) and AIM Rule 15.

The Company will no longer be subject to the AIM Rules once Cancellation has occurred. In the event that Cancellation occurs before a binding agreement is entered into for the sale of the Business to Microsaic, the requirements of AIM Rule 13 and 15 would cease to apply to the transaction.

The Independent Director expects that if the Transaction occurs, it is likely to occur at a point following Cancellation.

Further updates will be given as appropriate.

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMZMZZZGRGFZM
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.